- Home
- TTRX vs INO Comparison
TTRX vs INO Comparison
Compare TTRX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTRX | INO |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 114.0M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | TTRX | INO |
|---|---|---|
| Price | $3.28 | $1.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $8.00 | $6.75 |
| AVG Volume (30 Days) | 16.7K | ★ 695.8K |
| Earning Date | 05-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | N/A | $24,407.60 |
| Revenue Next Year | N/A | $331.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $2.57 | $1.30 |
| 52 Week High | $5.98 | $2.86 |
Technical Indicators
Market Signals| Indicator | TTRX | INO |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 49.54 |
| Support Level | $2.94 | $1.48 |
| Resistance Level | $3.83 | $1.78 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 3.97 | 55.56 |
Price Performance
Historical ComparisonAbout TTRX Turn Therapeutics Inc.
Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.